AI governance in life sciences research means having clear, checkable controls over where your data lives, who can access it, whether it's used to train a vendor's model, and whether every AI-generated claim can be traced back to its source. Data security specifically is one part of that picture: encryption, access controls, and where data physically resides. Governance is the broader discipline that also covers accountability, auditability, and whether an AI system's output can be trusted under regulatory or medical scrutiny.
AI governance frameworks exist because "is this AI safe to use" isn't a single yes-or-no question, it's a set of specific, checkable controls. Two frameworks come up most often in 2026: the NIST AI Risk Management Framework, a voluntary framework designed to help organizations build trustworthiness into how AI systems are designed, deployed, and used, and ISO/IEC 42001, the international standard specifically for AI management systems. Organizations are increasingly using the two together rather than picking one.
Regulation is also catching up specifically to healthcare. The EU AI Act treats many healthcare-related AI systems, particularly those used in clinical decision-making, as "high-risk," which generally means mandatory risk management processes, technical documentation, and a formal conformity assessment before deployment. In life sciences specifically, AI governance sits close to patient safety and regulatory scrutiny, not just data privacy in the abstract.
Three risks come up repeatedly when pharma organizations evaluate an AI vendor:
An evidence trail is the ability to trace an AI-generated claim back to the specific source, a dataset, a transcript, a deck, that it came from. This matters more in life sciences than in most industries because a research deliverable can inform a launch strategy, a message platform, or a claim that gets reviewed by medical, legal, and regulatory stakeholders before it's used. "The AI said so" isn't a citation. A reviewer needs to be able to check a claim against its source the same way they'd check a colleague's citation in a research memo, not take an AI-generated answer on faith.
Whatever platform or tool a team is evaluating, these are the specific things worth checking, not just asking whether it's "secure":
Sagan Agents is built with pharma procurement requirements in mind, not adapted from a consumer product afterward. Client data sovereignty is a design principle, an organization's data stays inside its own environment rather than moving into shared infrastructure. The platform supports SSO integration, role-based access controls, audit logging, and bring-your-own-API-key deployment.
The evidence trail piece runs through the platform by design as well. Every answer from Data Archive Intelligence is sourced and cited back to the original deck, dataset, or transcript it came from, and every workflow runs on a visible, editable roadmap rather than a black box, the mechanics we cover in more depth in Human-in-the-Loop AI: How Sagan Agents Combines AI Speed With Expert Judgment.
The clearest way to evaluate an AI platform's governance is to see whether you can trace an actual answer back to its source. Visit the Sagan Agents page to see the full platform, or use the form below to start a conversation about a pilot.